Drug Profile
Remeglurant
Alternative Names: MRZ-8456Latest Information Update: 11 May 2016
Price :
$50
*
At a glance
- Originator Merz Pharmaceuticals
- Class Analgesics; Antiparkinsonians; Anxiolytics; Quinolones
- Mechanism of Action Metabotropic glutamate receptor 5 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Drug-induced dyskinesia
Most Recent Events
- 11 May 2016 Chemical structure information added
- 05 May 2016 No recent reports on development identified - Phase-I for Drug-induced dyskinesia in USA (unspecified route)